๐ง ๐๏ธ๐ Susac's syndrome is a rare autoimmune microangiopathy affecting the
brain, retina, and cochlea.
๐ก Always consider in young women with hearing loss + visual disturbance + encephalopathy.
Classical triad = 1) Sensorineural hearing loss, 2) Branched Retinal Artery Occlusions (BRAOs), 3) Encephalopathy.
๐ Introduction
- First described by John O. Susac in 1979.
- Autoimmune endotheliopathy causing microinfarctions in the cochlea, retina, and brain.
- Predominantly affects young women.
๐บ Classical Triad
- ๐ง Subacute encephalopathy.
- ๐๏ธ Retinal arteriolar branch occlusions (BRAOs).
- ๐ Sensorineural hearing loss.
๐งฌ Aetiology / Pathology
- Microangiopathy with microinfarcts in cochlea, retina, corpus callosum.
- Corpus callosum = most frequently affected region.
- Possible role of anti-endothelial cell antibodies.
๐ Clinical Features
- ๐ง Cognitive changes: headache, memory loss, personality change, confusion, seizures.
- ๐ถ Ataxia, migrainous headaches, delirium.
- ๐๏ธ Acute visual loss from BRAOs.
- ๐ Asymmetric, bilateral sensorineural hearing loss (low-frequency loss).
- ๐ Typically monophasic, lasting 2โ4 years; may relapse, especially in pregnancy.
๐งช Investigations
- ๐งช Bloods: Often normal (FBC, U&E, CRP).
- ๐ CSF: โ protein, mild lymphocytosis.
- ๐งฒ MRI: Pathognomonic findings:
- Central corpus callosum lesions ("snowball" lesions).
- โString of pearlsโ or โspoke lesionsโ along the callosal roof.
- Leptomeningeal enhancement (โ
cases).
- ๐ Fluorescein angiography: BRAOs.
- ๐ง Audiogram: Low-frequency sensorineural loss.
๐ผ๏ธ Imaging Examples
โ๏ธ Differential Diagnoses
- Atypical MS or ADEM.
- CADASIL, SLE, APL syndrome, vasculitis.
- Neuro-Behรงetโs disease.
- Lymphoma, temporal arteritis.
- Coganโs syndrome (ocular + vestibuloauditory, no encephalopathy).
๐ Management
- ๐ฏ Immunotherapy (mainstay):
- IV methylprednisolone, then oral prednisolone taper.
- IVIG or plasmapheresis for refractory/active disease.
- Immunosuppressants: azathioprine, mycophenolate, rituximab, cyclophosphamide.
- ๐ Hearing loss: Intratympanic dexamethasone may give temporary relief.
- ๐ Monitoring: Serial MRI, audiometry, and fluorescein angiography to track disease activity.
- ๐ง Course is usually self-limiting (2โ4 yrs), but relapse prevention and close follow-up essential.
๐ References